![]() Xencor Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. | ![]() Bio-Path Holdings Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company. | |||
Founding Date | Founding Date 2016 | Founding Date 1997 | Founding Date 2007 | Founding Date 2001 |
Type | Type Private | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations San Diego, US HQ | Locations Pasadena, US HQ San Diego, US | Locations Bellaire, US HQ | Locations San Diego, US HQ |
Employees | Employees 614% decrease | Employees 2604% increase | Employees 913% increase | Employees 1 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.5 b | Valuation ($) 4 m | Valuation ($) N/A |
Financial | ||||
Net income | Net income N/A | Net income ($92.1m) (FY, 2025) | Net income ($9.9m) (FY, 2024) | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round $ 5.4m (over 3 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 22.5m (over 17 years ago) |
Total funding raised | Total funding raised $ 5.4m | Total funding raised $ 108.4m | Total funding raised $ 2.3m | Total funding raised $ 23m |

Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.
View company
Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company.
View company
Splash Pharmaceuticals is a cancer therapy company.
View company